Steve Girouard brings a dynamic blend of technical expertise and strategic insight to C2C, empowering MedTech startups to navigate the complex journey from concept to commercialization. With a deep understanding of biomedical engineering and a keen eye for innovation, Steve specializes in translating cutting-edge technologies into viable, market-ready solutions.

As the Managing Director of Ten15 Ventures, Steve has been instrumental in identifying and nurturing transformative medical technologies, providing both capital and strategic guidance to early-stage companies. His hands-on approach has been pivotal in accelerating product development, securing regulatory approvals, and achieving successful market entry.

Steve's advisory roles extend to several high-impact startups, including Galvanize Therapeutics, ONWARD Medical, and Attune Medical, where he offers critical insights into clinical strategy and operational execution. His board memberships at AtaCor Medical, LUMA Vision, PolyVascular, and Prima Medical further underscore his commitment to advancing medical innovation.

Steve’s contributions to MedTech are backed by over 45 U.S. patents and numerous peer-reviewed publications, reflecting a rare blend of scientific depth and real-world impact.

At C2C, Steve leverages his extensive background to guide clients through the intricacies of medical device development, from initial concept through to successful market launch, ensuring that innovative ideas become impactful healthcare solutions.

​

EDUCATION

​

• PhD, Biomedical Engineering - Case Western Reserve University, Cleveland, OH, USA

• MS, Biomedical Engineering - Case Western Reserve University, Cleveland, OH, USA

• BS, Biomedical Engineering - Boston University, Boston, MA, USA

​​​